JNJ
$263.04 at the check
NEUTRAL

Kairon's answer on JNJ: no clear edge.

Checked Jul 5, 2026 at $263.04 · time frame 3-6 months · confidence low
Result check on Jan 1, 2027: open.
Get the result by email

The 10-second check

Loading filings…

Both sides

More for

Consistent revenue growth in a stable sector supports the investment thesis that JNJ is capable of sustaining healthy operational performance, making the stock a defensible long-term investment.

The significant gap above the 200-day moving average indicates strength in the stock's trend, supported by a bullish market environment, which adds to the likelihood of continued positive performance.

More against

If this relatively high valuation compresses to the sector average of 24x, it suggests that the stock price may need to adjust downwards significantly.

These low metrics indicate potential concerns over quality of earnings and cash generation relative to reported earnings, suggesting that earnings might not be sustainable or repeatable.

Read the full debate between the bull and the bear analyst

Bull Analyst: ### BULL CASE ARGUMENTS

Argument 1 - Category: Valuation [HIGH conviction]
Evidence: Forward P/E of 20.68x vs sector average of 24x, indicating undervaluation.
Thesis: JNJ is trading at a lower valuation compared to its peers, suggesting potential for upward price adjustment. This discrepancy positions JNJ as an attractive investment, assuming the company can maintain its growth trajectory.

Argument 2 - Category: Growth [MEDIUM conviction]
Evidence: Revenue of $96.36 billion with a 10% YoY growth and Net Income of $21.04 billion reflecting a 2% growth YoY.
Thesis: Consistent revenue growth in a stable sector supports the investment thesis that JNJ is capable of sustaining healthy operational performance, making the stock a defensible long-term investment.

Argument 3 - Category: Technical [HIGH conviction]
Evidence: Current price at $263.04, positioned 21.05% above 200 SMA.
Thesis: The significant gap above the 200-day moving average indicates strength in the stock's trend, supported by a bullish market environment, which adds to the likelihood of continued positive performance.

Argument 4 - Category: Momentum [MEDIUM conviction]
Evidence: JNJ has outperformed SPY over 30 days with a return of +8.77% vs SPY's +4.54%, and also over 90 days with +9.80% vs +6.21%.
Thesis: This strong relative performance shows investor confidence and enhances the stock's credibility as a potential long-term holding, suggesting that market sentiment is shifting positively toward JNJ.

Argument 5 - Category: Risk/Reward [MEDIUM conviction]
Evidence: R/R Ratio of 3.25:1 calculated based on price targets, indicating favorable risk metrics.
Thesis: With a well-structured risk/reward setup, the potential for gains outweighs downside risk, making an investment in JNJ attractive, especially for investors seeking balanced risk exposure.

### BEAR COUNTER-ARGUMENTS

Bear said: Free cash flow has declined sharply to $1.47 billion, suggesting potential liquidity issues and operational pressures moving forward.
Counter: While free cash flow has decreased significantly (down 73% QoQ), the company still maintains a solid operating cash flow of $2.51 billion, which is indicative of continued profitability in operations and the ability to reinvest into core business growth.

Bear said: The fundamental score is relatively low at 4.6/10, indicating concerns over earnings quality and profitability.
Counter: Despite the fundamental score, profitability metrics reveal a net margin of 21.83% and a Return on Equity (ROE) of 26.42%, providing strong evidence of operational efficiency and profitability that can support continued growth.

### BULL THESIS INVALIDATION LEVEL
The bull thesis breaks if the stock closes below $255.00 (the designated stop-loss level), signifying a potential shift in market sentiment and invalidating the technical support dynamics.

### OVERALL BULL CONVICTION: HIGH (8-10)
Justify: The bull case has three HIGH conviction arguments with strong supporting data that indicate undervaluation and solid growth potential, alongside a favorable market regime and positive technical indicators. Despite some legitimate concerns regarding cash flow, the overall risk/reward dynamics lean heavily towards bullish sentiment.
Bear Analyst: ### BEAR CASE RISKS

Risk 1 - Category: Fundamental [HIGH conviction]
Evidence: Free Cash Flow (FCF) has declined sharply to $1.47 billion, down 73% QoQ, while Total Debt has increased by 14.66% QoQ to $54.99 billion.
Risk: A significant drop in FCF raises concerns about the company’s ability to manage debt, invest in growth, and return capital to shareholders. This decline may signal operational inefficiencies or intensifying competitive pressures that could further impact profitability.
Quantified downside: If FCF insecurity continues, leading to further declines, the stock could drop by approximately 30% based on historical performance of similar declines in liquidity among industry peers.

---

Risk 2 - Category: Valuation [HIGH conviction]
Evidence: JNJ’s P/E ratio stands at 30.48x compared to a sector average of 24x, with a Forward P/E still elevated at 20.68x.
Risk: If this relatively high valuation compresses to the sector average of 24x, it suggests that the stock price may need to adjust downwards significantly. The spread indicates that the market may overestimate the company's future earnings growth potential relative to its peers.
Quantified downside: A decline to a P/E of 24x could imply a stock price reduction of around 21% given current earnings, indicating significant downside.

---

Risk 3 - Category: Earnings Quality [MEDIUM conviction]
Evidence: Operating Cash Flow (OCF) to Net Income (NI) ratio is at 47.08% and Free Cash Flow margin is at 1.52%.
Risk: These low metrics indicate potential concerns over quality of earnings and cash generation relative to reported earnings, suggesting that earnings might not be sustainable or repeatable. This could prompt additional scrutiny from investors and analysts, driving the stock price lower.
Quantified downside: If earnings quality deteriorates further, leading to market corrections in perceived value, the stock could fall by around 15%, reflecting historical adjustments for companies facing similar conditions.

---

Risk 4 - Category: Debt/Equity [MEDIUM conviction]
Evidence: JNJ's Debt to Equity ratio stands at 67.73%, significantly high compared to a sector average of 1.1x.
Risk: A high leverage ratio raises concerns about financial stability, especially in potentially rising interest rate environments. If interest earnings weaken or debt servicing becomes challenging, it could lead to credit rating downgrades and increased costs of borrowing, further straining FCF.
Quantified downside: Should the perceived risk of insolvency or higher servicing costs materialize, a market reaction could drive the stock price down by 20% based on historical responses to similar leverage changes among comparables.

---

Risk 5 - Category: Market Sentiment [MEDIUM conviction]
Evidence: RSI at 73.41 indicates an overbought condition, alongside a MACD histogram suggesting a nearing momentum reversal.
Risk: These technical indicators show that the stock may be losing upward momentum, potentially leading to a sell-off as investors take profits. This profit-taking could trigger a broader correction, particularly if economic indicators shift or earnings disappoint later.
Quantified downside: A reversal following a sell-off could lead to a price adjustment of 10%-15% from its peak, consistent with prior market corrections during similar technical signals.

---

### BULL COUNTER-ARGUMENTS

Bull said: Forward P/E of 20.68x indicates undervaluation compared to its peers.
Counter: The higher absolute P/E of current 30.48x, nearly 27% above the sector average, suggests the market may have already priced in the expected growth, leaving little room for multiple expansion if results do not meet high expectations.

Bull said: Revenue of $96.36 billion with a 10% YoY growth ensures strong operational performance.
Counter: While revenue appears solid, the slower growth rate in Net Income (2% YoY) alongside a declining FCF indicates that the growth is not translating effectively into increased profitability or cash performance.

Bull said: Current price at $263.04 is positioned 21.05% above the 200 SMA.
Counter: This strong technical positioning is misleading; such a high gap from the 200-day moving average often indicates overextension which precedes pullbacks, especially when compounded with high valuation and sentiment risks present.

Bull said: JNJ has consistently outperformed SPY over the last 30 and 90 days.
Counter: Past performance does not guarantee future results, especially in a broader context where economic signals may change rapidly. Pressure in other market segments could lead to a reversion to the mean, where JNJ does not hold its relative advantage.

Bull said: The R/R Ratio of 3.25:1 indicates favorable risk metrics.
Counter: A favorable R/R ratio may not account for underlying risks such as declining cash flow, elevated valuation metrics, and weak earnings quality that could skew this ratio favorably without adequate justification.

---

### RED FLAGS FROM ANALYST REPORTS

- Free Cash Flow is negative on a QoQ basis, down to $1.47 billion (-73%).
- Current ratio at 1.025 indicates minimal liquidity cushion.
- Cash conversion ratio (OCF/NI) at only 47.08%, indicating declining quality of earnings.

---

### BEAR THESIS CONFIRMATION SIGNAL

The bear thesis accelerates if: JNJ’s stock price closes below $240 (a significant support level and approximately 9% below the current price), or if the OCF/NI ratio drops below 0.4 in the next reporting period, indicating further weakened operational cash flow relative to net income.

---

### OVERALL BEAR CONVICTION: HIGH (8-10)
Justify: The bear case is supported by multiple high conviction risks, including concerns around cash flow, leverage, and earnings quality alongside concerning technical indicators which could lead to significant downside if market conditions change. The prevalence of red flags only strengthens the case for a cautious stance on JNJ.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on JNJ

1 past checks: 0 directional calls (0 right, 0 wrong), 1 × wait (afterwards −3.8 % on average). Measured by price since each check, no costs. How we measure · Every 'not now' answer

Jul 5, 2026 · Wait at $263.04 · anyone who bought anyway: −3.8 %wait

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$242.49
Resistance$268.00
Horizon3-6 months

Executive summary

Given a conviction score below the minimum threshold of 7, the outlook on JNJ is unfavorable for trading. The potential for a binary event in the near future adds significant risk, reducing the likelihood of stable returns. Current mixed technical and fundamental signals further complicate the investment case.

Investment thesis

While JNJ remains above key moving averages and has shown strong performance relative to the market, the impending earnings event introduces a binary risk that overshadows potential returns. Additionally, the RSI indicates overbought territory and declining free cash flow raises concerns about future performance, contributing to a lower conviction score.

Key risks

The threat of a negative earnings reaction and overbought RSI complicate the bullish thesis; technical indicators, while positive, show signs of potential pullback.

AI-generated. Created 2026-07-05 11:54 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $263.04. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure · every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum · Privacy · Terms · Disclaimer